-
Mashup Score: 6
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high mortality and morbidity. We aimed to determine the relative benefits of pharmacological prophylactic treatments in patien
Source: StrokeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention - PubMed - 3 year(s) ago
In this largest series to date, intracoronary nicardipine was demonstrated to be a safe and highly effective pharmacological agent to reverse no-reflow during PCI.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
No-reflow poll➡️Adenosine #1. Our drug of choice @TJUHospital is #nicardipine >98% success without the HR & BP AE of other drugs➡️ https://t.co/lehiUJ2xrt @CCIJournal @fischman_david @mmamas1973 @SVRaoMD @mirvatalasnag @GreggWStone @agtruesdell @willsuh76 @Hragy #CardioTwitter https://t.co/lz2nMzpdmI
-
#STROKE #Meta-Analysis reports #nimodipine and #cilostazol improved disability, whereas #clazosentan, #nicardipine, #fasudil and #magnesium reduced delayed cerebral ischemia in aneurysmal #SAH https://t.co/wmypF6Apoe https://t.co/oth3jHvgbM